Abbott Laboratories - 36 Year Stock Price History | ABT

Historical daily share price chart and data for Abbott Laboratories since 1983 adjusted for splits. The latest closing stock price for Abbott Laboratories as of April 18, 2019 is 73.92.
  • The all-time high Abbott Laboratories stock price is 80.06, which is 8.3% above the current share price.
  • The Abbott Laboratories 52-week high stock price is 80.06, which is 8.3% above the current share price.
  • The Abbott Laboratories 52-week low stock price is 57.09, which is 22.8% below the current share price.
  • The average Abbott Laboratories stock price for the last 52 weeks is 68.34.
Abbott Laboratories Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 75.0105 69.1758 80.0600 65.9111 73.9200 2.68%
2018 63.4985 57.4736 73.9235 55.2713 71.9926 29.04%
2017 47.0879 37.3157 56.1831 37.3157 55.7921 52.00%
2016 38.3145 40.0140 43.0058 34.0902 36.7042 -12.32%
2015 42.7892 40.9734 47.4440 36.1946 41.8595 1.89%
2014 37.0686 34.1231 42.3148 32.1788 41.0829 20.08%
2013 31.6249 28.1518 34.5516 28.1518 34.2124 23.75%
2012 26.3385 23.5714 30.4438 22.5969 27.6455 18.31%
2011 21.0762 19.5236 23.4093 18.5194 23.3677 19.46%
2010 20.5743 21.8843 22.6780 18.5671 19.5603 -9.84%
2009 19.3376 21.1859 22.7237 16.5514 21.6954 2.77%
2008 21.7051 21.8042 23.6975 19.5602 21.1108 -3.77%
2007 21.1646 18.9154 23.0832 18.9154 21.9371 16.59%
2006 17.3088 15.0820 19.0544 15.0820 18.8150 25.13%
2005 17.2177 17.5973 18.9512 14.3498 15.0362 -14.52%
2004 15.5513 16.3030 17.7180 13.7564 17.5898 8.24%
2003 14.3352 13.8192 16.4425 11.8945 16.2507 17.74%
2002 15.7530 19.0838 19.7527 10.6686 13.8020 -27.56%
2001 17.0614 16.3230 19.4016 14.2930 19.0530 15.98%
2000 14.1041 11.7753 18.9073 9.9910 16.4281 34.48%
1999 14.6346 16.2926 17.7433 11.2067 12.2160 -25.40%
1998 13.6429 11.2153 16.6268 11.0905 16.3762 50.34%
1997 10.2323 8.3356 11.4132 8.3356 10.8926 29.72%
1996 7.4813 6.8748 9.3896 6.3879 8.3968 22.49%
1995 6.3251 5.3460 7.3403 5.1268 6.8551 28.23%
1994 4.8506 4.7047 5.5098 4.2621 5.3460 10.76%
1993 4.3627 4.9207 4.9207 3.7414 4.8268 -1.91%
1992 4.9635 5.4285 5.4987 4.3631 4.9207 -11.49%
1991 4.1999 3.4834 5.5592 3.2034 5.5592 53.39%
1990 3.0685 2.7838 3.6646 2.5333 3.6243 32.59%
1989 2.3740 1.9169 2.8191 1.8726 2.7335 41.47%
1988 1.8792 1.9496 2.0853 1.7250 1.9322 -0.11%
1987 2.3046 1.9030 2.6800 1.7239 1.9343 5.82%
1986 1.7572 1.3610 2.1771 1.2762 1.8280 33.58%
1985 1.0909 0.8126 1.4037 0.8002 1.3685 63.89%
1984 0.8586 0.9193 0.9598 0.7600 0.8350 -7.66%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $129.838B $30.578B
Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $112.952B 16.51
Stryker (SYK) United States $67.256B 24.66
Boston Scientific (BSX) United States $48.820B 23.72
Baxter (BAX) United States $37.991B 24.37
Zimmer Biomet Holdings (ZBH) United States $24.550B 15.71
Smith & Nephew SNATS (SNN) United Kingdom $16.615B 0.00
Canopy Growth (CGC) Canada $14.912B 0.00
ResMed (RMD) United States $14.218B 26.96
Aurora Cannabis (ACB) Canada $9.118B 64.29
Bio-Rad Laboratories (BIO) United States $8.765B 50.28
Perrigo (PRGO) Ireland $6.633B 10.75
Hill-Rom Holdings (HRC) United States $6.374B 19.72
Insulet (PODD) United States $4.900B 1642.60
GW Pharmaceuticals (GWPH) United Kingdom $4.701B 0.00
ICU Medical (ICUI) United States $4.568B 28.29
Haemonetics (HAE) United States $4.189B 37.16
Hutchison China MediTech (HCM) China $4.046B 0.00
Agios Pharmaceuticals (AGIO) United States $3.268B 0.00
Neogen (NEOG) United States $2.958B 48.10
NuVasive (NUVA) United States $2.784B 24.18
Quidel (QDEL) United States $2.365B 21.17
National Vision Holdings (EYE) United States $2.220B 43.66
Aphria (APHA) $1.917B 0.00
HEXO (HEXO) $1.424B 0.00
Phibro Animal Health (PAHC) United States $1.349B 19.38
VAREX IMAGING (VREX) United States $1.222B 23.93
Cardiovascular Systems (CSII) United States $1.190B 854.00
AtriCure (ATRC) United States $1.049B 0.00
Lantheus Holdings (LNTH) United States $0.931B 25.16
Omeros (OMER) United States $0.908B 0.00
PetIQ (PETQ) United States $0.862B 24.67
MacroGenics (MGNX) United States $0.791B 0.00
Cerus (CERS) United States $0.787B 0.00
NanoString Technologies (NSTG) United States $0.737B 0.00
TG Therapeutics (TGTX) United States $0.689B 0.00
Evolus (EOLS) United States $0.681B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.666B 22.66
OraSure Technologies (OSUR) United States $0.594B 25.86
Surmodics (SRDX) United States $0.546B 79.43
LeMaitre Vascular (LMAT) United States $0.536B 25.46
Meridian Bioscience (VIVO) United States $0.531B 15.82
Quanterix (QTRX) United States $0.492B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.322B 0.00
Utah Medical Products (UTMD) United States $0.321B 20.88
Insys Therapeutics (INSY) United States $0.313B 0.00
BioLife Solutions (BLFS) United States $0.305B 125.85
Vapotherm (VAPO) United States $0.296B 0.00
Rockwell Medical (RMTI) United States $0.271B 0.00
Cytosorbents (CTSO) United States $0.219B 0.00
Owens & Minor (OMI) United States $0.213B 2.91
Zynex (ZYXI) United States $0.171B 18.31
Chimerix (CMRX) United States $0.133B 0.00
Bovie Medical (APYX) United States $0.131B 0.00
Fonar (FONR) United States $0.125B 6.68
Chembio Diagnostics (CEMI) United States $0.121B 0.00
Surface Oncology (SURF) United States $0.113B 0.00
InfuSystems Holdings (INFU) United States $0.090B 0.00
Female Health (VERU) United States $0.088B 0.00
United-Guardian (UG) United States $0.088B 20.06
CAS Medical Systems (CASM) United States $0.072B 0.00
Neurotrope (NTRP) United States $0.071B 0.00
Trinity Biotech (TRIB) Ireland $0.071B 21.00
Oramed Pharmaceuticals (ORMP) United States $0.070B 0.00
ImmuCell (ICCC) United States $0.043B 0.00
Senestech (SNES) United States $0.034B 0.00
Valeritas Holdings (VLRX) United States $0.031B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.025B 0.00
Myomo (MYO) United States $0.021B 0.00
Capricor Therapeutics (CAPR) United States $0.018B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Akers Biosciences Inc (AKER) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 13.71